Early PCSK9 Inhibition in AMI Yields Plaque Regression

"Go early and go low" is an expert's response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received alirobumab.
Medscape Medical News

source https://www.medscape.com/viewarticle/971582?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost